Stock Track | REMEGEN Plummets 5% Intraday as BlackRock Reduces Stake

Stock Track12-01

REMEGEN's stock fell sharply by 5% during Monday's intraday trading session, following news of a stake reduction by BlackRock.

According to Hong Kong Stock Exchange filings, BlackRock sold 185,500 shares of REMEGEN at HK$81.6411 per share on November 25, totaling approximately HK$15.14 million. This reduced BlackRock's ownership to 4.99%, down from its previous stake. Institutional selling often signals waning confidence and can trigger broader market reactions, contributing to the stock's decline.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment